Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kappa B pathway inhibition

	Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kappa B pathway inhibition
	Li, Peng; Wang, Shiyun; Li, Rongwei; Zhang, Yanyan; Yao, Yao; Shi, Pengcheng; Dong, Huijuan; Chen, Feili; Zha, Jie; Xu, Bing
刊名	JOURNAL OF TRANSLATIONAL MEDICINE
	2014
卷号	12
ISSN号	1479-5876
学科主题	Research & Experimental Medicine
语种	英语
内容类型	期刊论文
源URL	[http://ir.foo.ac.cn/handle/2SETSVCV/534]
专题	中国科学院广州生物医药与健康研究院
推荐引用方式 GB/T 7714	Li, Peng,Wang, Shiyun,Li, Rongwei,et al. Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kappa B pathway inhibition[J]. JOURNAL OF TRANSLATIONAL MEDICINE,2014,12.
APA	Li, Peng.,Wang, Shiyun.,Li, Rongwei.,Zhang, Yanyan.,Yao, Yao.,...&Wang, Weiguang.(2014).Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kappa B pathway inhibition.JOURNAL OF TRANSLATIONAL MEDICINE,12.
MLA	Li, Peng,et al."Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kappa B pathway inhibition".JOURNAL OF TRANSLATIONAL MEDICINE 12(2014).